Enter your terms above and click the 'Search' button.

Showing articles 0 to 8 of 8 Filter Applied: cabergoline (Click to remove) Prolactinomas NEJM 362:1219-1226, Klibanski,A., 2010 Valvular Heart Disease and the Use of Dopamine Agonists for Parkinsons Disease NEJM 356:39-46, Zanettini,R.,et al, 2007 Dopamine Agonists and the Risk of Cardiac Valve Regurgitation NEJM 356:29-38, Schade,R.,et al, 2007 Dopamine Agonists and Cardiac Valvulopathy in Parkinson Disease: A Case-Control Study Neurol 67:1225-1229, Yamamoto,M.,et al, 2006 Acromegaly NEJM 355:2558-2573, Melmed,S., 2006 Cabergoline-Related Severe Restrictive Mitral Regurgitation NEJM 353:1974-1975, Rosen,C.J., 2005 Prolactinoma NEJM 349:2035-2041, Schlechte,J.A., 2003 Pleuropulmonary Disease Associated with Dopamine Agonist Therapy Ann Neurol 30:613-616, Bhatt,M.H.,et al, 1991 Showing articles 0 to 8 of 8